Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731236 · ClinicalTrials.gov registry record · Early Phase 1
CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease
A Early Phase 1 study of Dietary Modification, sponsored by The Cleveland Clinic.
- Active
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01731236: Active Early Phase 1 study of Dietary Modification, sponsored by The Cleveland Clinic.
NCT01731236 is a Early Phase 1 study of Dietary Modification that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 217-participant average among 5 other Dietary Modification trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01731236, a Early Phase 1 study of Dietary Modification, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The principal goal for the study is to examine the role gut flora plays in modulating metabolism of dietary carnitine and choline in humans.
Primary Outcome
Plasma levels of carnitine and multiple gut flora metabolites
Conditions Studied
Interventions
- DRUG Antibiotics
- DIETARY_SUPPLEMENT Choline
- DIETARY_SUPPLEMENT Carnitine
- DRUG Choline and Aspirin
- DRUG Carnitine and Aspirin
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-02-11 |
| Est. Completion | 2029-12 |
| Phase | Early Phase 1 |
What the registry record for NCT01731236 still lists
NCT01731236 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 217-participant average among 5 other Dietary Modification trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Dietary Modification appearing as the primary indexed condition, and to 5 interventions - of which Antibiotics is the first listed.
NCT01731236 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01731236 about?
NCT01731236 is a clinical study titled "CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease". The principal goal for the study is to examine the role gut flora plays in modulating metabolism of dietary carnitine and choline in humans.
What is the current status of trial NCT01731236?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2011-02-11. Estimated completion is 2029-12.
What conditions does trial NCT01731236 study?
This clinical trial studies the following conditions: Dietary Modification.
What interventions are being tested in trial NCT01731236?
The interventions under investigation include: Antibiotics (DRUG), Choline (DIETARY_SUPPLEMENT), Carnitine (DIETARY_SUPPLEMENT), Choline and Aspirin (DRUG), Carnitine and Aspirin (DRUG).
Who is sponsoring clinical trial NCT01731236?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01731236 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dietary Modification
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
ACTIVE NOT RECRUITING · Phase 2
-
Metabolomics for Identifying Biomarkers of Dietary Intake and Kidney Disease Progression
COMPLETED · NA
-
Nutricity: A Pilot Study to Improve Parental Nutrition Literacy
COMPLETED · NA
-
Spinal Cord Injury Exercise and Nutrition Conceptual Engagement
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI